Skip to main content
Premium Trial:

Request an Annual Quote

Alan Koontz, John Spreadbury, Jonathan Burbaum


Imaging software company Nonlinear Dynamics said last week that Alan Koontz, its Asia Pacific general managner, had passed away in Tokyo following a sudden heart attack on September 16. His funeral will be held September 27 at a ceremony at Pierce Brothers Valhalla Cemetery in North Hollywood, California. Inquiries should be directed to John Spreadbury, the company’s group sales and marketing director.

ActivX Biosciences has promoted Jonathan Burbaum to the newly created position of vice president for advanced technology, the La Jolla, Calif.-based company said last week. In his new position, Burbaum will be responsible for developing several proteomics platforms in the areas of high-throughput screening, capillary electrophoresis, and mass spectrometry. During his tenure as executive director for advanced technology, Burbaum helped design ActivX’s automated protein analysis system for use with the company’s activity-based chemical probes. Burbaum has worked for Pharmacopeia and Merck Research Laboratories, where he held positions in high-throughput screening technology development and basic protein science, respectively.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.